New York State Common Retirement Fund Codiak Bio Sciences, Inc. Transaction History

New York State Common Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$2.24 - $6.96 $24,192 - $75,168	-10,800 Reduced 98.79%	132 $0
Q4 2021 Feb 02, 2022	SELL	$10.0 - $16.78 $170 - $285	-17 Reduced 0.16%	10,932 $122,000
Q3 2021 Nov 02, 2021	SELL	$15.58 - $22.88 $40,539 - $59,533	-2,602 Reduced 19.2%	10,949 $179,000
Q2 2021 Aug 02, 2021	BUY	$11.72 - $26.81 $111,937 - $256,062	9,551 Added 238.78%	13,551 $251,000
Q4 2020 Feb 08, 2021	BUY	$7.9 - $32.3 $31,600 - $129,199	4,000 New	4,000 $129,000

238K

Ticker CDAK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,995,200
Market Cap $360K
Description
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.